Senzar Asset Management Lowers stake in Laboratory Corp. of America Holdings (LH)

Laboratory Corp. of America Holdings (LH) : Senzar Asset Management reduced its stake in Laboratory Corp. of America Holdings by 31.55% during the most recent quarter end. The investment management company now holds a total of 86,800 shares of Laboratory Corp. of America Holdings which is valued at $12,156,340 after selling 40,000 shares in Laboratory Corp. of America Holdings , the firm said in a disclosure report filed with the SEC on Aug 12, 2016.Laboratory Corp. of America Holdings makes up approximately 2.42% of Senzar Asset Management’s portfolio.

Other Hedge Funds, Including , Blackrock Japan Ltd boosted its stake in LH in the latest quarter, The investment management firm added 295 additional shares and now holds a total of 125,319 shares of Laboratory Corp. of America Holdings which is valued at $17,550,926. Laboratory Corp. of America Holdings makes up approx 0.06% of Blackrock Japan Ltd’s portfolio.Klingenstein Fields Co boosted its stake in LH in the latest quarter, The investment management firm added 11,856 additional shares and now holds a total of 207,603 shares of Laboratory Corp. of America Holdings which is valued at $29,091,408. Laboratory Corp. of America Holdings makes up approx 1.33% of Klingenstein Fields Co’s portfolio. Meeder Asset Management Inc added LH to its portfolio by purchasing 2,710 company shares during the most recent quarter which is valued at $376,202. Laboratory Corp. of America Holdings makes up approx 0.03% of Meeder Asset Management Inc’s portfolio.

Laboratory Corp. of America Holdings opened for trading at $136.19 and hit $138.1799 on the upside on Monday, eventually ending the session at $137.74, with a gain of 1.25% or 1.7 points. The heightened volatility saw the trading volume jump to 5,17,521 shares. Company has a market cap of $14,091 M.

On the company’s financial health, Laboratory Corp. of America Holdings reported $2.31 EPS for the quarter, beating the analyst consensus estimate by $ 0.01 according to the earnings call on Jul 27, 2016. Analyst had a consensus of $2.30. The company had revenue of $2382.00 million for the quarter, compared to analysts expectations of $2334.01 million. The company’s revenue was up 7.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.09 EPS.

Laboratory Corporation of America Holdings is an independent clinical laboratory company in the United States. Through a national network of laboratories the Company offers a range of clinical laboratory tests that are used by the medical profession in core testing patient diagnosis and in the monitoring and treatment of disease. The Company manages its operations through two segments: the Clinical diagnostics laboratory segment which includes core testing as well as genomic and esoteric testing; and the Other segment which consists of the Company’s non-United States clinical diagnostic laboratory operations in Ontario Canada. It also provides specialty testing services in the areas of allergy clinical trials diagnostic genetics women’s health cardiovascular disease identity forensics infectious disease endocrinology oncology coagulation occupational testing and pain management.

Leave a Reply

Laboratory Corp. of America Holdings - Is it time to Sell?

Top Brokerage Firms are advising their investors on Laboratory Corp. of America Holdings. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.